Nucleolin: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
[[ | {{Infobox protein | ||
''' | | name = Nucleolin | ||
| image = <!-- Image removed --> | |||
| caption = <!-- Image caption --> | |||
| symbol = NCL | |||
| alt_symbols = C23 | |||
| EntrezGene = 4691 | |||
| HGNCid = 7651 | |||
| OMIM = 164035 | |||
| RefSeq = NM_005381 | |||
| UniProt = P19338 | |||
| PDB = 1FJE | |||
}} | |||
'''Nucleolin''' (NCL) is a [[protein]] that in humans is encoded by the '''NCL''' [[gene]]. Nucleolin is a major [[nucleolar]] [[phosphoprotein]] that is associated with [[ribosomal RNA]] (rRNA) and is involved in the synthesis and maturation of [[ribosomes]]. | |||
== Function == | |||
Nucleolin plays a critical role in the [[nucleolus]], where it is involved in the synthesis and maturation of [[ribosomal RNA]] (rRNA) and the assembly of [[ribosomes]]. It is also implicated in various cellular processes such as [[chromatin]] remodeling, [[DNA]] replication, [[transcription]], and [[cell cycle]] regulation. Nucleolin is known to interact with [[nucleic acids]] and various [[proteins]], influencing [[gene expression]] and [[cell proliferation]]. | |||
== Structure == | == Structure == | ||
Nucleolin is a | Nucleolin is a multi-domain protein that contains several [[RNA-binding domains]] and a [[glycine]]-rich domain. The protein is highly phosphorylated, which is important for its function in the nucleolus. The structure of nucleolin allows it to bind to [[rRNA]] and other nucleic acids, facilitating the processing and assembly of ribosomal subunits. | ||
The | == Clinical significance == | ||
== | Nucleolin has been implicated in various [[diseases]], including [[cancer]]. It is often overexpressed in [[tumor]] cells and is associated with increased [[cell proliferation]] and [[tumorigenesis]]. Nucleolin is considered a potential target for [[cancer therapy]], and several [[therapeutic]] strategies are being explored to inhibit its function in cancer cells. | ||
== Interactions == | == Interactions == | ||
Nucleolin interacts with a | Nucleolin interacts with a variety of proteins and nucleic acids. It binds to [[rRNA]], [[mRNA]], and [[DNA]], and interacts with proteins involved in [[ribosome biogenesis]], [[chromatin remodeling]], and [[signal transduction]]. These interactions are crucial for its role in regulating [[gene expression]] and [[cell cycle]] progression. | ||
== References == | == References == | ||
{{ | <references/> | ||
[[Category: | |||
[[Category: | == External links == | ||
[[Category: | * {{PDB|1FJE}} | ||
* [https://www.ncbi.nlm.nih.gov/gene/4691 Nucleolin gene information at NCBI] | |||
{{Protein-stub}} | |||
[[Category:Human proteins]] | |||
[[Category:Genes on human chromosome 2]] | |||
[[Category:RNA-binding proteins]] | |||
[[Category:Phosphoproteins]] | |||
[[Category:Oncology]] | |||
Latest revision as of 20:41, 30 December 2024
Nucleolin (NCL) is a protein that in humans is encoded by the NCL gene. Nucleolin is a major nucleolar phosphoprotein that is associated with ribosomal RNA (rRNA) and is involved in the synthesis and maturation of ribosomes.
Function[edit]
Nucleolin plays a critical role in the nucleolus, where it is involved in the synthesis and maturation of ribosomal RNA (rRNA) and the assembly of ribosomes. It is also implicated in various cellular processes such as chromatin remodeling, DNA replication, transcription, and cell cycle regulation. Nucleolin is known to interact with nucleic acids and various proteins, influencing gene expression and cell proliferation.
Structure[edit]
Nucleolin is a multi-domain protein that contains several RNA-binding domains and a glycine-rich domain. The protein is highly phosphorylated, which is important for its function in the nucleolus. The structure of nucleolin allows it to bind to rRNA and other nucleic acids, facilitating the processing and assembly of ribosomal subunits.
Clinical significance[edit]
Nucleolin has been implicated in various diseases, including cancer. It is often overexpressed in tumor cells and is associated with increased cell proliferation and tumorigenesis. Nucleolin is considered a potential target for cancer therapy, and several therapeutic strategies are being explored to inhibit its function in cancer cells.
Interactions[edit]
Nucleolin interacts with a variety of proteins and nucleic acids. It binds to rRNA, mRNA, and DNA, and interacts with proteins involved in ribosome biogenesis, chromatin remodeling, and signal transduction. These interactions are crucial for its role in regulating gene expression and cell cycle progression.
References[edit]
<references/>
External links[edit]